CA2222995A1 - Ionic molecular conjugates of n-acylated derivatives of poly(2-amino-2-deoxy-d-glucose) and polypeptides - Google Patents

Ionic molecular conjugates of n-acylated derivatives of poly(2-amino-2-deoxy-d-glucose) and polypeptides

Info

Publication number
CA2222995A1
CA2222995A1 CA002222995A CA2222995A CA2222995A1 CA 2222995 A1 CA2222995 A1 CA 2222995A1 CA 002222995 A CA002222995 A CA 002222995A CA 2222995 A CA2222995 A CA 2222995A CA 2222995 A1 CA2222995 A1 CA 2222995A1
Authority
CA
Canada
Prior art keywords
deoxy
polypeptides
glucose
poly
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002222995A
Other languages
French (fr)
Other versions
CA2222995C (en
Inventor
Shalaby W. Shalaby
Steven A. Jackson
Francis Ignatious
Jacques-Pierre Moreau
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ipsen Manufacturing Ireland Ltd
Original Assignee
Biomeasure, Incorporated
Shalaby W. Shalaby
Steven A. Jackson
Francis Ignatious
Jacques-Pierre Moreau
Societe De Conseils De Recherches Et D'applications Scientifiques, S.A.S .
Kinerton Limited
Ipsen Manufacturing Ireland Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomeasure, Incorporated, Shalaby W. Shalaby, Steven A. Jackson, Francis Ignatious, Jacques-Pierre Moreau, Societe De Conseils De Recherches Et D'applications Scientifiques, S.A.S ., Kinerton Limited, Ipsen Manufacturing Ireland Limited filed Critical Biomeasure, Incorporated
Publication of CA2222995A1 publication Critical patent/CA2222995A1/en
Application granted granted Critical
Publication of CA2222995C publication Critical patent/CA2222995C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0024—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
    • C08B37/0027—2-Acetamido-2-deoxy-beta-glucans; Derivatives thereof
    • C08B37/003—Chitin, i.e. 2-acetamido-2-deoxy-(beta-1,4)-D-glucan or N-acetyl-beta-1,4-D-glucosamine; Chitosan, i.e. deacetylated product of chitin or (beta-1,4)-D-glucosamine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/31—Somatostatins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Materials Engineering (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Polymers & Plastics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polyamides (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
  • Other Resins Obtained By Reactions Not Involving Carbon-To-Carbon Unsaturated Bonds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)

Abstract

A copolymer comprising an N-acylated derivative, and a composition comprising said copolymer and a polypeptide, said polypeptide comprising at least one effective ionogenic amine, wherein at least 50 percent, by weight, of said polypeptide present in said composition is ionically bound to said polymer.
CA002222995A 1995-06-06 1996-05-24 Ionic molecular conjugates of n-acylated derivatives of poly(2-amino-2-deoxy-d-glucose) and polypeptides Expired - Fee Related CA2222995C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/468,947 1995-06-06
US08/468,947 US5665702A (en) 1995-06-06 1995-06-06 Ionic molecular conjugates of N-acylated derivatives of poly(2-amino-2-deoxy-D-glucose) and polypeptides
PCT/US1996/007756 WO1996039160A1 (en) 1995-06-06 1996-05-24 Ionic molecular conjugates of n-acylated derivatives of poly(2-amino-2-deoxy-d-glucose) and polypeptides

Publications (2)

Publication Number Publication Date
CA2222995A1 true CA2222995A1 (en) 1996-12-12
CA2222995C CA2222995C (en) 2005-05-10

Family

ID=23861854

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002222995A Expired - Fee Related CA2222995C (en) 1995-06-06 1996-05-24 Ionic molecular conjugates of n-acylated derivatives of poly(2-amino-2-deoxy-d-glucose) and polypeptides

Country Status (21)

Country Link
US (2) US5665702A (en)
EP (1) EP0830137B1 (en)
JP (1) JPH11508289A (en)
KR (1) KR19990022399A (en)
CN (1) CN1192152A (en)
AT (1) ATE245031T1 (en)
AU (1) AU717188B2 (en)
BR (1) BR9609031A (en)
CA (1) CA2222995C (en)
CZ (1) CZ391697A3 (en)
DE (1) DE69629114T2 (en)
DK (1) DK0830137T3 (en)
ES (1) ES2201188T3 (en)
HU (1) HUP9901627A3 (en)
NZ (1) NZ308909A (en)
PL (1) PL323735A1 (en)
PT (1) PT830137E (en)
RU (1) RU2172323C2 (en)
SI (1) SI9620090A (en)
SK (1) SK168397A3 (en)
WO (1) WO1996039160A1 (en)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6090925A (en) 1993-03-09 2000-07-18 Epic Therapeutics, Inc. Macromolecular microparticles and methods of production and use
US5981719A (en) 1993-03-09 1999-11-09 Epic Therapeutics, Inc. Macromolecular microparticles and methods of production and use
US6479457B2 (en) * 1995-06-06 2002-11-12 Kinerton Limited Ionic molecular conjugates of N-acylated derivatives of poly(2-amino-2-deoxy-D-glucose) and polypeptides
US5968895A (en) 1996-12-11 1999-10-19 Praecis Pharmaceuticals, Inc. Pharmaceutical formulations for sustained drug delivery
PL193111B1 (en) * 1998-01-29 2007-01-31 Poly Med Inc Absorbable microparticles
DE69907870T2 (en) 1998-01-29 2004-03-04 Kinerton Ltd., Blanchardstown METHOD FOR PRODUCING ABSORBABLE MICROPARTICLES
CZ303120B6 (en) 1998-12-07 2012-04-11 Societe De Conseils De Recherches Et Dapplications Scientifiques S. A. Compound and pharmaceutical composition
JP4532618B2 (en) * 1999-02-25 2010-08-25 株式会社グライコメディクス Novel sugar primer
US7037889B2 (en) 2000-09-13 2006-05-02 Praecis Pharmaceuticals Inc. Pharmaceutical compositions for sustained drug delivery
US7122622B2 (en) * 2002-04-16 2006-10-17 Biosynthema Inc. Peptide compounds having improved binding affinity to somatostatin receptors
US7244445B2 (en) 2002-07-29 2007-07-17 Poly Med, Inc Conformable, absorbable, solid composite preforms and their use for bone tissue engineering
CA2504345A1 (en) * 2002-10-31 2004-05-13 Pfizer Products Inc. Liquid conjugates of solid pharmaceuticals
US9221867B2 (en) 2003-01-06 2015-12-29 Angiochem Inc. Method for transporting a compound across the blood-brain barrier
ES2393335T3 (en) 2003-12-16 2012-12-20 Ipsen Pharma GLP-1 analogues
EP1915167A4 (en) 2005-07-08 2010-04-07 Ipsen Pharma Melanocortin receptor ligands
EP2471555A3 (en) 2005-07-15 2012-10-17 Angiochem Inc. Use of aprotinin polypeptides as carriers in pharmaceutical conjugates
US9365634B2 (en) 2007-05-29 2016-06-14 Angiochem Inc. Aprotinin-like polypeptides for delivering agents conjugated thereto to tissues
EP2650006A1 (en) 2007-09-07 2013-10-16 Ipsen Pharma S.A.S. Analogues of exendin-4 and exendin-3
AU2008325194B2 (en) 2007-11-05 2012-04-19 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Use melanocortins to treat insulin sensitivity
US8841440B2 (en) * 2008-04-01 2014-09-23 Cornell University Organo-soluble chitosan salts and chitosan-derived biomaterials prepared thereof
RU2509809C2 (en) 2008-07-04 2014-03-20 Транслэшионал Кэнсэр Драгз Фарма, С.Л. Methods of treating and diagnosing cancer
AU2009280012B2 (en) 2008-08-07 2012-12-06 Ipsen Pharma S.A.S. Truncated analogues of glucose-dependent insulinotropic polypeptide
WO2010016940A2 (en) 2008-08-07 2010-02-11 Ipsen Pharma S.A.S. Analogues of glucose-dependent insulinotropic polypeptide
CA2733006A1 (en) 2008-08-07 2010-02-11 Ipsen Pharma S.A.S. Analogues of glucose-dependent insulinotropic polypeptide (gip) modified at n-terminal
US8828925B2 (en) 2008-10-15 2014-09-09 Angiochem Inc. Etoposide and doxorubicin conjugates for drug delivery
EP2346906A4 (en) 2008-10-15 2013-04-24 Angiochem Inc Conjugates of glp-1 agonists and uses thereof
JP5759379B2 (en) 2008-12-05 2015-08-05 アンジオケム インコーポレーテッド Neurotensin or neurotensin analog and use thereof
BRPI0922611A2 (en) 2008-12-17 2018-11-06 Angiochem Inc type 1 membrane matrix metalloprotein inhibitors and uses thereof
US20110293562A1 (en) 2009-02-12 2011-12-01 Proyecto De Biomedicina Cima, S.L. Use of cardiotrophin-1 for the treatment of metabolic diseases
EP2448965A4 (en) 2009-07-02 2015-02-11 Angiochem Inc Multimeric peptide conjugates and uses thereof
US8759299B2 (en) 2009-07-22 2014-06-24 Ipsen Pharma S.A.S. Analogues of insulin-like growth factor-1 (IGF-1) having amino acid substitution at position 59
US9415012B2 (en) * 2011-06-14 2016-08-16 Ipsen Pharma S.A.S. Sustained-release composition containing peptides as active ingredient
US9962401B2 (en) * 2011-09-27 2018-05-08 Purdue Research Foundation Chitosan derivatives for inactivation of endotoxins and surface protection of nanoparticles
EP3307326B9 (en) 2015-06-15 2021-02-24 Angiochem Inc. Methods for the treatment of leptomeningeal carcinomatosis

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4675189A (en) * 1980-11-18 1987-06-23 Syntex (U.S.A.) Inc. Microencapsulation of water soluble active polypeptides
IE52535B1 (en) * 1981-02-16 1987-12-09 Ici Plc Continuous release pharmaceutical compositions
JPS63258579A (en) * 1987-04-15 1988-10-26 Fuji Boseki Kk Production of carrier for immobilization of physiologically active substance
US5271945A (en) * 1988-07-05 1993-12-21 Takeda Chemical Industries, Ltd. Sustained release microcapsule for water soluble drug
EP0544000B1 (en) * 1990-08-17 1997-05-02 Drug Delivery System Institute, Ltd. N-acetylcarboxymethylchitosan derivative and production thereof
US5298488A (en) * 1990-10-26 1994-03-29 Fuji Photo Film Co., Ltd. CM-chitin derivatives and use thereof
IT1243390B (en) * 1990-11-22 1994-06-10 Vectorpharma Int PHARMACEUTICAL COMPOSITIONS IN THE FORM OF PARTICLES SUITABLE FOR THE CONTROLLED RELEASE OF PHARMACOLOGICALLY ACTIVE SUBSTANCES AND PROCEDURE FOR THEIR PREPARATION.
US5344644A (en) * 1991-08-01 1994-09-06 Takeda Chemical Industries, Ltd. Water-soluble composition for sustained-release

Also Published As

Publication number Publication date
CA2222995C (en) 2005-05-10
DE69629114D1 (en) 2003-08-21
CZ391697A3 (en) 1998-05-13
SI9620090A (en) 1998-08-31
HUP9901627A1 (en) 1999-09-28
EP0830137A1 (en) 1998-03-25
BR9609031A (en) 1999-12-14
EP0830137B1 (en) 2003-07-16
EP0830137A4 (en) 2002-06-26
ATE245031T1 (en) 2003-08-15
JPH11508289A (en) 1999-07-21
WO1996039160A1 (en) 1996-12-12
ES2201188T3 (en) 2004-03-16
AU717188B2 (en) 2000-03-23
PT830137E (en) 2003-10-31
DE69629114T2 (en) 2004-04-22
PL323735A1 (en) 1998-04-14
US5665702A (en) 1997-09-09
NZ308909A (en) 1999-06-29
CN1192152A (en) 1998-09-02
DK0830137T3 (en) 2003-11-03
RU2172323C2 (en) 2001-08-20
KR19990022399A (en) 1999-03-25
HUP9901627A3 (en) 1999-11-29
AU5878996A (en) 1996-12-24
SK168397A3 (en) 1998-04-08
US5821221A (en) 1998-10-13

Similar Documents

Publication Publication Date Title
CA2222995A1 (en) Ionic molecular conjugates of n-acylated derivatives of poly(2-amino-2-deoxy-d-glucose) and polypeptides
AU8090294A (en) Non-antigenic branched polymer conjugates
CA2204640A1 (en) Conjugates of bdnf and nt-3 with a water-soluble polymer
CA2323048A1 (en) Poly(ethylene glycol) derivatives with proximal reactive groups
CA2283939A1 (en) Non-antigenic branched polymer conjugates
CA2191088A1 (en) Copolymer-1 improvements in compositions of copolymers
AU6004896A (en) Preparation of low molecular weight, highly reactive polyisobutene
EP1695718A3 (en) Biodegradable polyester and Ionic molecular conjugates of biodegradable polyesters and bioactive polypeptides
RU98100091A (en) ION MOLECULAR CONJUGATES OF N-ACYLATED DERIVATIVES OF POLY (2-AMINO-2-DEOXY-D-GLUCOSE) AND POLYPEPTIDES
MY118538A (en) Polymeric compositions and their production and uses
AU6581696A (en) High strength, melt processable, lactide-rich, poly (lactide-co-p-dioxanone) copolymers
AU4401897A (en) Supramolecular polymer
CA2268433A1 (en) Improved interferon polymer conjugates
CA2258849A1 (en) Oxidized oligosaccharides
IL136054A0 (en) Poly(vinylamine) -based superabsorbent gels and method of manufacturing the same
AU5858690A (en) Polymer/antibiotic conjugate
AU4201496A (en) Reducing composition comprising a basic amino acid and a cationic polymer
EP0335312A3 (en) Intraocular lens
NO981833D0 (en) Water-redispersible powdery film-forming polymer blend
AU6213190A (en) Blends of carbonate polymer, polyacetal and compatibilizer
AU4477293A (en) A process for melt blending high molecular weight ethylene polymer and low molecular weight ethylene polymer
NO20011744L (en) Ionic molecular conjugates of N-acylated derivatives of poly (2-amino-2-deoxy-d-glucose) and polypeptides
CA2121522A1 (en) Thermoplastic polymer composition
AU6748190A (en) Ignition resistant carbonate polymer blend compositions
CA2249215A1 (en) Modified pectin material

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed